Zum Inhalt springen
LURIC

Publikation · PMID 40806466

Comparing Inflammatory Biomarkers in Cardiovascular Disease: Insights from the LURIC Study

Moissl AP, Delgado GE, Scharnagl H, Siekmeier R, Krämer BK, Duerschmied D, März W, Kleber ME

The combined prognostic utility of hsCRP, SAA, and IL-6 was evaluated in 3300 LURIC participants undergoing coronary angiography. Co-elevation of these markers characterised a high-risk cardiometabolic phenotype; associations of hsCRP and SAA with mortality weakened on adjustment for IL-6, which alone achieved the highest predictive power (AUC: 0.638). The findings support multi-marker inflammatory profiling for refining cardiovascular risk stratification.

International Journal of Molecular Sciences, 29. Juli 2025 | PMID 40806466

Zeitschrift
International Journal of Molecular Sciences
DOI
10.3390/ijms26157335
PMID
40806466
Quelle
https://pubmed.ncbi.nlm.nih.gov/40806466/
Zitationen
7 Relative Zitationsrate 2.23 (1,0 = Durchschnitt des Fachgebiets) · NIH iCite, Stand 16.08.2026 · vorläufig, die Arbeit ist für einen endgültigen Wert noch zu neu